http://goldbamboo.com/ Chlorambucil News from GoldBamboo.com en-us © 2005, Gold Bamboo LLC, All Rights Reserved http://goldbamboo.com/news-a211042.html Genzyme Corporation (Nasdaq: GENZ) and Berlex Inc., a U.S. affiliate of Schering AG, Germany (FSE: SCH), majority-owned by the Bayer Group, today announced results from CAM307, an international Phase III clinical trial comparing Campath(R) (alemtuzumab) with chlorambucil in previously untreated patients with B-cell chronic lymphocytic leukemia (B-CLL). [click link for full article] Tue, 12 Dec 2006 08:00 EST http://goldbamboo.com/news-a211044.html Patients with B-cell chronic lymphocytic leukemia (B-CLL) may soon have a more effective treatment option earlier in the course of their disease, according to final data from the CAM 307 international Phase III study presented today at the 48th Annual Meeting of the American Society of Hematology. [click link for full article] Tue, 12 Dec 2006 08:00 EST